2022-11-04T23:28:44+03:00[Europe/Moscow] en true <p>sulfinyl sulfur</p>, <p>racemate</p>, <p>proton pump inhibitor; Gastroesophageal disease</p>, <p>esomeprazole; omeprazole</p>, <p>Amphiphilic</p>, <p>Amphotecerin B MOA/indication</p>, <p>50-150 kcal/mol</p>, <p>5-10 kcal/mol</p>, <p>2-5 kcal/mol</p>, <p>0.5-1 kcal/mol</p>, <p>aspirin, penicilin, omeprazole, clopidogrel, neratinib </p>, <p>cyclooxygenase inhibitor; prevents the conversion of arachidonic acid to thromboxane A(2).</p>, <p>B-lactamase inhibitor; inhibits transpeptidase that catalyzes the final step in cell wall formation; the cross-linking of peptidoglycan</p>, <p>anticancer drug; inhibits EGFR</p>, <p>CYP2C19</p>, <p>omeprazole, esomeprazole</p>, <p>covalent</p>, <p>irreversible; destruction; resynthesize new receptors</p>, <p>decreases the strength</p>, <p>b</p>, <p>true</p>, <p>hydrogen bond acceptor</p>, <p>hydrogen bond donor </p>, <p>carboxylate ion, phosphate ion, tertiary amine</p>, <p>carboxylic acid, amide oxygen, ketone, ester, ethyl, alcohol</p>, <p>sulfur, fluorine, chlorine, aromatic ring, amide nitrogen, aromatic amine</p>, <p>-nib</p>, <p>increased binding to enzyme/receptor &amp; absorption through membrane</p>, <p>decreased aqueous solubility; increased binding to P450, blood proteins, hERG heart ion channel</p>, <p>logP &lt;=5, MW &lt; =500, HBD &lt;=5, HBA &lt;=10 </p>, <p>Rotatable bonds &lt;= 10, Polar surface area &lt;= 140, total HA + HB &lt;= 12</p>, <p>Amide C-N </p>, <p>benzodiazepine; privileged structure; CCK antagonist</p>, <p>Privileged structure</p>, <p>indole; privileged structure; CCK antagonist</p>, <p>diphenylmethane; privelged structure; benadryl</p>, <p>can bind to multiple targets causing side effects; hard to develop patens</p>, <p>&lt;=30</p>, <p>Atenolol</p>, <p>Amitryptiline</p>, <p>b</p>, <p>Benadryl</p>, <p>CYP2D6, CYP1A2; CYP2C9, CYP2C19; CYP2D6</p>, <p>warfarin or vitamin k antagonist; fenofibrate can enhance anticoagulant effect </p> flashcards
Ch. 1 - Molecular Diversity

Ch. 1 - Molecular Diversity

  • sulfinyl sulfur

    Omeprazole contains a:

    triazole

    thiazole

    phenyl ring

    sulfinyl sulfur

  • racemate

    Omeprazole is a :

    racemate

    prodrug

    active

  • proton pump inhibitor; Gastroesophageal disease

    Esomeprazole MOA & indication.

  • esomeprazole; omeprazole

    _____________ is twice as effective as ___________.

  • Amphiphilic

    - local anesthetics that interact hydrophobically and electrostatically with lipid bilayers; directly inhibiting membrane functions and inhibition of channel functions.

  • Amphotecerin B MOA/indication

    antifungal; forms barrel-like structure w hydrophilic environment that allows for ions to flow into cell damaging it and leading to cell death

  • 50-150 kcal/mol

    What is the strength of covalent interactions?

  • 5-10 kcal/mol

    What is the strength of electrostatic interactions?

  • 2-5 kcal/mol

    What is the strength of hydrogen bond interactions?

  • 0.5-1 kcal/mol

    What is the strength of hydrophobic interactions?

  • aspirin, penicilin, omeprazole, clopidogrel, neratinib

    What are our covalent inhibitors?

  • cyclooxygenase inhibitor; prevents the conversion of arachidonic acid to thromboxane A(2).

    Aspirin class & MOA?

  • B-lactamase inhibitor; inhibits transpeptidase that catalyzes the final step in cell wall formation; the cross-linking of peptidoglycan

    Penicillin class & MOA?

  • anticancer drug; inhibits EGFR

    Neratinib indication & MOA

  • CYP2C19

    Clopidogrel is metabolized by ______

  • omeprazole, esomeprazole

    CYP219 inhibitors such as, __________ & ___________ can decrease the antiplatelet effect of clopidogrel.

  • covalent

    Which bonds are the strongest in drug-receptor interactions?

  • irreversible; destruction; resynthesize new receptors

    Covalent bonds will result in ________binding. This leads to _________ of the receptor. Cells must ____________

  • decreases the strength

    How does distance affect the strength of electrostatic bonds?

  • b

    Strongest Electrostatic interactions occur where?

    a)Hydrophilic environments

    b)hydrophobic environments

    c)Neutral environments

    d)none of the above

  • true

    Ionic bonds are the most important initial interactions as a drug enters the binding site. T/F

  • hydrogen bond acceptor

    -electron rich heteroatom

  • hydrogen bond donor

    -electron deficient hydrogen

  • carboxylate ion, phosphate ion, tertiary amine

    What are our strong hydrogen bond acceptors?

  • carboxylic acid, amide oxygen, ketone, ester, ethyl, alcohol

    What are our moderate hydrogen bond acceptors

  • sulfur, fluorine, chlorine, aromatic ring, amide nitrogen, aromatic amine

    What are our poor hydrogen bond acceptors

  • -nib

    What suffix helps indicate it is an anti-cancer drug?

  • increased binding to enzyme/receptor & absorption through membrane

    What are the benefits of a high LogP?

  • decreased aqueous solubility; increased binding to P450, blood proteins, hERG heart ion channel

    What are potential downsides to high LogP?

  • logP <=5, MW < =500, HBD <=5, HBA <=10

    What are Lipinski's guidelines?

  • Rotatable bonds <= 10, Polar surface area <= 140, total HA + HB <= 12

    What are Veber's rules?

  • Amide C-N

    Which type of bonds don't apply to Veber's rotatable bond rule?

  • benzodiazepine; privileged structure; CCK antagonist

    What is the name of this structure?What is special about it?

    What is the name of this structure?

    What is special about it?

  • Privileged structure

    - common structures or molecular fragments that can be found regularly among active sets of molecules.

    - have the universal ability to bind to several protein targets

  • indole; privileged structure; CCK antagonist

    What is the name of this structure?What is special about it?What is its class?

    What is the name of this structure?

    What is special about it?

    What is its class?

  • diphenylmethane; privelged structure; benadryl

    What is the name of this structure?What is special about it?What drug is it found in?

    What is the name of this structure?

    What is special about it?

    What drug is it found in?

  • can bind to multiple targets causing side effects; hard to develop patens

    What are some negatives associated with privileged structures?

  • <=30

    How many nonhydrogen atoms can be on a drug for it to be included in the drug space?

  • Atenolol

    beta blocker, blocks binding of catecholamines to beta-1 receptors; beta-1 selective, hypertension, abrupt discontinuation can lead to myocardial infarction

  • Amitryptiline

    TCA, increases noradrenergic or serotonergic neurotransmission by blocking the ne or serotonin transporter, depression

  • b

    When Amitriptyline is metabolized by _______ it results in an active metabolite known as Nortriptyline.

    a) CYP2D6

    b) CYP2C19

    c) CYP3A4

    d) CYP2C9

  • Benadryl

    antihistamine, inverse agonist of H1 receptor, allergies

  • CYP2D6, CYP1A2; CYP2C9, CYP2C19; CYP2D6

    Enzymes at A, B, and C.

    Enzymes at A, B, and C.

  • warfarin or vitamin k antagonist; fenofibrate can enhance anticoagulant effect

    What drugs should be avoided when taking Fenofibrate? Why?